- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
FCS Case Study Shows High-Quality, Cost-Effective Care Delivered Through the Oncology Care Model
The shift to a value-based care platform through the Oncology Care Model was shown to stimulate a cost-effective, value-based platform for care delivery for FCS patients.
The shift to a value-based care platform fundamentally altered the drivers of patient satisfaction and resulting quality of life for patients at the Florida Cancer Specialists & Research Institute (FCS), but it also stimulated a cost-effective, value-based platform for care delivery across a growing subset of the population, according to findings of a case study.
In 2016, FCS, a community oncology practice serving nearly 100 locations in Florida, entered into the Oncology Care Model (OCM), which recently completed reporting for 9 of its initial payment periods. Key findings of the case study evaluating OCM and non-OCM practices included:
- reduction of expenditures amounting to $168 million, more than $120 million in net CMS savings
- FCS hospital admissions were 8% lower than those of other OCM-enrolled practices
- FCS had 21% fewer cases of emergency room visits
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Dr Lucio Gordan Discusses Updated Guidelines Addressing 1q Abnormalities in Multiple Myeloma
October 27th 2023Lucio Gordan, MD, president and managing physician of Florida Cancer Specialists & Research Institute, discusses recently updated clinical guidelines from the National Comprehensive Cancer Network (NCCN) in multiple myeloma, which specifically discuss disease staging and risk stratification and advise clinicians on how to address 1q abnormalities.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
